We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel 3D Imaging Technique Provides New Tool for Detecting Advanced Liver Fibrosis

By MedImaging International staff writers
Posted on 12 Apr 2016
Researchers have found that a new innovative 3D Magnetic Resonance Elastography (MRE) technique is a highly accurately, and less invasive method to diagnosis advanced liver fibrosis, instead of liver biopsies used today.

Non-Alcoholic Fatty Liver Disease occurs when large droplets of fat are deposited in the liver (hepatic steatosis), and can progress to liver fibrosis, cirrhosis, and cancer. NAFLD is widespread around the globe, and affects 33% or more of the general population in the US, and 50% of obese people.

The research was carried out at the UC San Diego School of Medicine NAFLD Research Center (San Diego, CA, USA) and published in the March 22, 2016, issue of the American Journal of Gastroenterology. The researchers conducted a prospective study that included 100 patients, 56% of them women, that had proven NAFLD. The researchers then assessed the effectiveness of 2D, and the new 3D MRE method. MRE is an Magnetic Resonance Imaging (MRI) technique that propagates mechanical shear waves in liver tissue. Tissue stiffness, an indicator of fibrosis, is measured quantitatively using an algorithm in MRE images.

Rohit Loomba, MD, director of the NAFLD Research Center, and first author of the study, said, “3D MRE is probably the most accurate noninvasive method to detect advanced fibrosis. The prospective study is the first to evaluate 3D-MRE for diagnosing advanced fibrosis in NAFLD patients. Both 2D and 3D were highly accurate. These findings suggest that MRE could be used to enroll patients with advanced fibrosis into screening programs for cirrhosis as well as enrollment into clinical trials aimed at reversing fibrosis in the setting of advanced fibrosis.”

Related Links:

UCSD School of Medicine NAFLD Research Center


Ultrasound Needle Guidance System
SonoSite L25
Half Apron
Demi
High-Precision QA Tool
DEXA Phantom
Mobile X-Ray System
K4W

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.